Cardiovascular Outcomes Of Diet Counseling

Sponsor
The Camelot Foundation (Other)
Overall Status
Completed
CT.gov ID
NCT00324545
Collaborator
GM Harrington, PhD (Other)
120
2
36
60
1.7

Study Details

Study Description

Brief Summary

(1) What effect does behavioral counseling for vegan, for low to moderate fat, and for lowered carbohydrate diets have on coronary blood flow? (2) What are the effects of different diet protocols when caloric intake and exercise are equalized? (3) Do people, so counseled, maintain their modified behaviors after they have completed their diet program? (4) How does targeting different diets affect secondary indices associated with heart disease such as weight, lipid, inflammatory, and thrombotic factors?

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Medium-intensity Minimally-directive Counseling
Phase 3

Detailed Description

Given the current epidemic of overweight and obesity on a global scale ("globesity") and the consequent world public health objective of reducing that obesity, it is evident as a practical matter that, the main line of attack must be through diet. The public health objective and the lack of information regarding the long-term public health effects of alternative weight-loss diets motivated this comparative study of the three major types of weight-loss diets and their long term effects on coronary blood flow. Secondary endpoints are inflammatory and other variables associated with heart disease and obesity.

Specifically we asked: (1) What effect does behavioral counseling for vegan, for low to moderate fat, and for lowered carbohydrate diets have on coronary blood flow? (2) What are the effects of different diet protocols when caloric intake and exercise are equalized? (3) Do people, so counseled, maintain their modified behaviors after they have completed their diet program? (4) How does targeting different diets affect secondary indices associated with heart disease such as weight, lipid, inflammatory, and thrombotic factors?

Study Design

Study Type:
Interventional
Actual Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Long-term Adherence and Cardiovascular Outcomes of a Randomized Controlled Trial of Medium-intensity Minimally-directive Counseling for Different Diets
Actual Study Start Date :
Jan 1, 2000
Actual Primary Completion Date :
Dec 31, 2002
Study Completion Date :
Dec 31, 2002

Outcome Measures

Primary Outcome Measures

  1. coronary blood flow []

Secondary Outcome Measures

  1. weight []

  2. BMI []

  3. LDLc []

  4. Total Cholesterol []

  5. HDLc []

  6. Triglycerides []

  7. Homocysteine []

  8. Fibrinogen []

  9. Lipoprotein (a) []

  10. VLDLc []

  11. TC/HDL []

  12. TG/HDL (Insulin Resistance) []

  13. CRP []

  14. IL-6 []

  15. respiratory quotient []

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 59 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

Inclusion criteria: BMI greater than 30,

Exclusion criteria: pre-existing co-morbid diseases (documented heart disease, diabetes mellitus, cancer, hypertension, hepatic, renal or gastrointestinal disease), pregnancy or plans for pregnancy. Participants could not be smokers (cigarettes, cigars, pipes or chewing tobacco), take medications (prescription or over the counter medications with the exception of antibiotics), nor take vitamin or mineral supplements. Additionally, they could not currently be on a diet or have been on one during the last 6 months, or have food allergies that would influence food choices.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Keith Block Chicago Illinois United States 60201
2 Richard M. Fleming, MD Omaha Nebraska United States 68114

Sponsors and Collaborators

  • The Camelot Foundation
  • GM Harrington, PhD

Investigators

  • Principal Investigator: Richard M Fleming, MD, Camelot Foundation
  • Principal Investigator: Gordon M Harrington, PhD, University of Northern Iowa

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
RM Fleming, MD, PI, The Camelot Foundation
ClinicalTrials.gov Identifier:
NCT00324545
Other Study ID Numbers:
  • 2000-1-1
First Posted:
May 11, 2006
Last Update Posted:
Jul 21, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by RM Fleming, MD, PI, The Camelot Foundation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 21, 2020